Trends in Characteristics and Outcomes of Patients Undergoing Coronary Revascularization in the United States, 2003-2016
- PMID: 32058558
- DOI: 10.1001/jamanetworkopen.2019.21326
Trends in Characteristics and Outcomes of Patients Undergoing Coronary Revascularization in the United States, 2003-2016
Erratum in
-
Clarification That Study Database Included Hospital Inpatients.JAMA Netw Open. 2020 Apr 1;3(4):e206536. doi: 10.1001/jamanetworkopen.2020.6536. JAMA Netw Open. 2020. PMID: 32343348 Free PMC article. No abstract available.
Abstract
Importance: Data on the contemporary changes in risk profile and outcomes of patients undergoing percutaneous coronary intervention (PCI) or coronary bypass grafting (CABG) are limited.
Objective: To assess the contemporary trends in the characteristics and outcomes of patients undergoing PCI or CABG in the United States.
Design, setting, and participants: This retrospective cohort study used a national inpatient claims-based database to identify patients undergoing PCI or CABG from January 1, 2003, to December 31, 2016. Data analysis was performed from July 15 to October 4, 2019.
Main outcomes and measures: Demographic characteristics, prevalence of risk factors, and clinical presentation divided into 3 eras (2003-2007, 2008-2012, and 2013-2016) and in-hospital mortality of PCI and CABG stratified by clinical indication.
Results: A total of 12 062 081 revascularization hospitalizations were identified: 8 687 338 PCIs (72.0%; mean [SD] patient age, 66.0 [10.8] years; 66.2% male) and 3 374 743 CABGs (28.0%; mean [SD] patient age, 64.5 [12.4] years; 72.1% male). The annual PCI volume decreased from 366 to 180 per 100 000 US adults and the annual CABG volume from 159 to 82 per 100 000 US adults. A temporal increase in the proportions of older, male, nonwhite, and lower-income patients and in the prevalence of atherosclerotic and nonatherosclerotic risk factors was found in both groups. The percentage of revascularization for myocardial infarction (MI) increased in the PCI group (22.8% to 53.1%) and in the CABG group (19.5% to 28.2%). Risk-adjusted mortality increased slightly after PCI for ST-segment elevation MI (4.9% to 5.3%; P < .001 for trend) and unstable angina or stable ischemic heart disease (0.8% to 1.0%; P < .001 for trend) but remained stable after PCI for non-ST-segment elevation MI (1.6% to 1.6%; P = .18 for trend). Risk-adjusted CABG morality markedly decreased in patients with MI (5.6% to 3.4% for all CABG and 4.8% to 3.0% for isolated CABG) and in those without MI (2.8% to 1.7% for all CABG and 2.1% to 1.2% for isolated CABG) (P < .001 for all).
Conclusions and relevance: Significant changes were found in the characteristics of patients undergoing PCI and CABG in the United States between 2003 and 2016. Risk-adjusted mortality decreased significantly after CABG but not after PCI across all clinical indications.
Comment in
-
Coronary Revascularization in the United States-Patient Characteristics and Outcomes in 2020.JAMA Netw Open. 2020 Feb 5;3(2):e1921322. doi: 10.1001/jamanetworkopen.2019.21322. JAMA Netw Open. 2020. PMID: 32058547 No abstract available.
Similar articles
-
Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).Circ Cardiovasc Qual Outcomes. 2016 May;9(3):197-205. doi: 10.1161/CIRCOUTCOMES.115.002084. Epub 2016 May 10. Circ Cardiovasc Qual Outcomes. 2016. PMID: 27166210
-
Temporal Trends in Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: Insights From the Washington Cardiac Care Outcomes Assessment Program.J Am Heart Assoc. 2020 Jun 2;9(11):e015317. doi: 10.1161/JAHA.119.015317. Epub 2020 May 27. J Am Heart Assoc. 2020. PMID: 32456522 Free PMC article.
-
Outcomes Following Percutaneous Coronary Intervention in Non-ST-Segment-Elevation Myocardial Infarction Patients With Coronary Artery Bypass Grafts.Circ Cardiovasc Interv. 2018 Nov;11(11):e006824. doi: 10.1161/CIRCINTERVENTIONS.118.006824. Circ Cardiovasc Interv. 2018. PMID: 30571201
-
Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.JACC Cardiovasc Interv. 2013 Dec;6(12):1219-30. doi: 10.1016/j.jcin.2013.07.008. JACC Cardiovasc Interv. 2013. PMID: 24355112 Review.
-
Long term outcomes of new generation drug eluting stents versus coronary artery bypass grafting for multivessel and/or left main coronary artery disease. A Bayesian network meta-analysis of randomized controlled trials.Cardiovasc Revasc Med. 2018 Sep;19(6):671-678. doi: 10.1016/j.carrev.2018.01.003. Epub 2018 Jan 5. Cardiovasc Revasc Med. 2018. PMID: 29396239 Review.
Cited by
-
Trends in the likelihood of receiving percutaneous coronary intervention in a low-volume hospital and disparities by sociodemographic communities.PLoS One. 2023 Jan 18;18(1):e0279905. doi: 10.1371/journal.pone.0279905. eCollection 2023. PLoS One. 2023. PMID: 36652416 Free PMC article.
-
Noninvasive flow evaluations of coronary artery bypass grafting using dynamic cardiac CT.Medicine (Baltimore). 2020 Nov 25;99(48):e23338. doi: 10.1097/MD.0000000000023338. Medicine (Baltimore). 2020. PMID: 33235098 Free PMC article.
-
Determinants of the Downward Trend in Coronary Artery Bypass Graft Surgery Among Patients With Multivessel Disease and Class-I Indication for Surgery.Cureus. 2021 Mar 25;13(3):e14098. doi: 10.7759/cureus.14098. Cureus. 2021. PMID: 33907642 Free PMC article.
-
Rates of Elective Percutaneous Coronary Intervention in England and Wales: Impact of COURAGE and ORBITA Trials.J Am Heart Assoc. 2022 Sep 20;11(18):e025426. doi: 10.1161/JAHA.122.025426. Epub 2022 Sep 14. J Am Heart Assoc. 2022. PMID: 36102261 Free PMC article.
-
P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention.J Cardiovasc Dev Dis. 2022 Oct 6;9(10):340. doi: 10.3390/jcdd9100340. J Cardiovasc Dev Dis. 2022. PMID: 36286292 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
